II.2.2) Additional CPV code(s)
85100000
II.2.3) Place of performance
NUTS code:
UKG2
II.2.4) Description of the procurement
There are approximately 2 900 000 people with diabetes mellitus in England, Diabetic retinopathy is a complication of diabetes and is one of the leading causes of blindness. Diabetic retinopathy, if left untreated, can lead to sight loss which can have devastating effect on individuals and their families.
Diabetic eye screening is just one component of diabetes care; the screening programme should be integrated within routine diabetes care. The aims of the Diabetic Eye Screening Programme (DESP) is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment if necessary of sight threatening diabetic retinopathy, at the appropriate stage during the disease process commissioners across NHS England and NHS Improvement — Midlands are looking to procure DESP provision across Staffordshire and Shropshire locality.
The service being commissioned should be aligned to the National Diabetic Eye Screening Service Specification Spec N0.22 2018/2019 which aims to ensure a consistent and equitable approach across England, and to govern the provision and monitoring of the DESP.
Staffordshire is a large geography area including Stoke-on-Trent, North Staffs, Staffordshire and Surrounds, Cannock Chase, East Staffordshire, and South East Staffordshire and Seisdon Peninsula. Access of screening will need to be considered carefully in order to deliver screening to all eligible patients who reside in Staffordshire. Current eligible cohort size is approximately 73 500 patients, with an expected annual growth between 5 % — 6 %.
Shropshire covers a large geographical footprint expanding across Telford and Wrekin with some cross border issues with the Welsh border. Due to the geography span there is a requirement that access points are considered to enable patient accessibility and uptake of the screening provision. Current eligible cohort size is approximately 30 000 patients, with an expected annual growth between 5 % — 7 %.
The service will need to undertake and perform the following objectives in order to meet the commissioning and service specification requirements:
— identify and validate the eligible population and ensure effective delivery with maximum coverage,
— deliver safe, effective, high quality, externally and independently monitored, and quality assured diabetic eye screening service,
— lead to earlier detection, appropriate referral, effective treatment and improved outcomes,
— support suitably trained, competent, and qualified clinical and non-clinical staff who, where relevant, participate in recognised on-going continuing medical education (CME), continuous Professional Development (CPD), and Quality Assurance (QA) schemes,
— have regular audits embedded within the service.
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Start:
01/01/2020
End:
31/12/2027
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
II.2.14) Additional information
As a result of this procurement exercise an agreement will be established with the successful bidder(s) for a period of 5 years [with the commissioner having the option to extend the contract for up to a further 2 years].